Accrued liabilities as of September 30, 2023 and December 31, 2022 consisted of the following:
September 30,
December 31,
2023
2022
Accrued personnel related costs
$
2,020
2,302
Accrued research and development expenses
6,830
3,122
Other accrued expenses
279
233
Total
9,129
5,657
No definition available.
Tabular disclosure of the components of accrued liabilities.